Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Osteosarcoma
>>
IGF
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
cixutumumab
(IMC A12) / Eli Lilly
figitumumab
(CP-751,871) / Novartis
robatumumab
(SCH 717454) / Merck (MSD)
ganitumab
(AMG 479) / Takeda, ImmunityBio